The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Diabetes control and complications: the role of glycated haemoglobin, 25 years on
Abstract
The long‐term complications of diabetes have major consequences for individual subjects and growing healthcare delivery and cost implications for society. Evidence for the benefits of good glycaemic control, as monitored by glycated haemoglobin measurements, has been developed in the 25 years since they were introduced to the point where HbA 1c assays play central roles in patient management, clinical guidance and audit, and clinical trial design. In this review this evidence is examined and three classes of uncertainty identified that diminish confidence in the effectiveness of these roles for HbA 1c. Analytical variability between different methods for HbA 1c has restricted the application of clinical targets and this problem has recently been addressed by reference method standardization. There are two approaches to this which result in different HbA 1c values and this discrepancy needs to be resolved. Biological variability in HbA 1c values between individuals also restricts its predictive role when applied to populations. The correlations between HbA 1c measurements and various components of glycaemia (overall, fasting, postprandial) are still uncertain and differences in protein glycation and de‐glycation are greater between subjects than often thought. The influence of variability in erythrocyte life span is an area where research is needed, especially in diabetic subjects. Clinical variability is the most important and complex area of uncertainty. A predictive link between HbA 1c and clinical outcomes is not as clear‐cut as often stated. The correlation with the development of microvascular disease is well established in Type 1 diabetes, but in Type 2 subjects (90% of those with diabetes) the evidence that HbA 1c monitoring is of value in predicting or preventing macrovascular disease is not strong, although it is the major cause of morbidity and early death in this group. It is recommended that, as a matter of urgency, these issues be examined, particularly within the context of self‐care in diabetes. Diabet. Med. **, ***–*** (2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The challenge of complexity in health care
Plsek, P. E., & Greenhalgh, T. (2001) · BMJ · doi:10.1136/bmj.323.7313.625 · Cited by 2,578
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Correlation of Glucose Regulation and Hemoglobin AIcin Diabetes Mellitus
Koenig, R. J., Peterson, C. M., Jones, R. L., Saudek, C., Lehrman, M., & Cerami, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950804 · Cited by 1,175
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Khaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017
Defining the Relationship Between Plasma Glucose and HbA1c
Rohlfing, C. L., Wiedmeyer, H.-M., Little, R. R., England, J. D., Tennill, A., & Goldstein, D. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.275 · Cited by 987
Coping with complexity: educating for capability
Fraser, S. W., & Greenhalgh, T. (2001) · BMJ · doi:10.1136/bmj.323.7316.799 · Cited by 889
The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus
Bunn, H. F., Gabbay, K. H., & Gallop, P. M. (1978) · Science · doi:10.1126/science.635569 · Cited by 876
Complexity, leadership, and management in healthcare organisations
Plsek, P. E., & Wilson, T. (2001) · BMJ · doi:10.1136/bmj.323.7315.746 · Cited by 754
Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., & Yasue, H. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00168-0 · Cited by 676
PubMed Central: creating an Aladdin's cave of ideas
Delamothe, T. (2001) · BMJ · doi:10.1136/bmj.322.7277.1 · Cited by 670
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
Approved IFCC reference method for the measurement of HbA1c in human blood
Jeppsson, J.-O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T., Miedema, K., Mosca, A., Mauri, P., Paroni, R., et al. (2002) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2002.016 · Cited by 655
Economic Consequences of Diabetes Mellitus in the U.S. in 1997
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.2.296 · Cited by 652
Glycation and Diabetic Complications
Brownlee, M. (1994) · Diabetes · doi:10.2337/diab.43.6.836 · Cited by 632
Diabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 597
Effect of Improved Glycemic Control on Health Care Costs and Utilization
Wagner, E. H. (2001) · JAMA · doi:10.1001/jama.285.2.182 · Cited by 536
(1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80683-3 · Cited by 536
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association, & National Institute of Diabetes, D. A. K. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s62 · Cited by 519
Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.775 · Cited by 464
Wilson, T., Holt, T., & Greenhalgh, T. (2001) · BMJ · doi:10.1136/bmj.323.7314.685 · Cited by 447
Bonora, E., & Muggeo, M. (2001) · Diabetologia · doi:10.1007/s001250100020 · Cited by 420
Testa, M. A., & Simonson, D. C. (1998) · JAMA · doi:10.1001/jama.280.17.1490 · Cited by 418
Avignon, A., Radauceanu, A., & Monnier, L. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1822 · Cited by 363
Engelgau, M. M., Thompson, T. J., Herman, W. H., Boyle, J. P., Aubert, R. E., Kenny, S. J., Badran, A., Sous, E. S., & Ali, M. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.785 · Cited by 325
Lithell, H., & Zethelius, B. (1998) · Cited by 304
Franciosi, M., Pellegrini, F., De Berardis, G., Belfiglio, M., Cavaliere, D., Di Nardo, B., Greenfield, S., Kaplan, S. H., Sacco, M., Tognoni, G., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1870 · Cited by 301
Lessons from the glitazones: a story of drug development
Gale, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04960-6 · Cited by 287
Bastyr, E. J., Stuart, C. A., Brodows, R. G., Schwartz, S., Graf, C. J., Zagar, A., & Robertson, K. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1236 · Cited by 274
ABC of arterial and venous disease: Vascular complications of diabetes
Donnelly, R. (2000) · BMJ · doi:10.1136/bmj.320.7241.1062 · Cited by 258
Role of Hyperglycemia in Nitrotyrosine Postprandial Generation
Ceriello, A., Quagliaro, L., Catone, B., Pascon, R., Piazzola, M., Bais, B., Marra, G., Tonutti, L., Taboga, C., & Motz, E. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1439 · Cited by 257
Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells
Delaney, C. L., Cheng, H.-L., & Feldman, E. L. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199912)41:4<540::aid-neu9>3.0.co;2-p · Cited by 253
Plasma Glucose Levels Throughout the Day and HbA1c Interrelationships in Type 2 Diabetes
Bonora, E., Calcaterra, F., Lombardi, S., Bonfante, N., Formentini, G., Bonadonna, R. C., & Muggeo, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2023 · Cited by 235
Group, T. D. C. A. C. T. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1711 · Cited by 205
US public health and the 21st century: diabetes mellitus
McKinlay, J., & Marceau, L. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02641-6 · Cited by 201
Ceriello, A., Bortolotti, N., Motz, E., Pieri, C., Marra, M., Tonutti, L., Lizzio, S., Feletto, F., Catone, B., & Taboga, C. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90237-8 · Cited by 198
Barzilay, J. I., Spiekerman, C. F., Wahl, P. W., Kuller, L. H., Cushman, M., Furberg, C. D., Dobs, A., Polak, J. F., & Savage, P. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12030-5 · Cited by 195
Glycosylated hemoglobins (GHb): an index of red cell survival
Panzer, S., Kronik, G., Lechner, K., Bettelheim, P., Neumann, E., & Dudczak, R. (1982) · Blood · doi:10.1182/blood.v59.6.1348.1348 · Cited by 192
HbA1c Levels Are Genetically Determined Even in Type 1 Diabetes
Snieder, H., Sawtell, P. A., Ross, L., Walker, J., Spector, T. D., & Leslie, R. D. G. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2858 · Cited by 189
Teno, S., Uto, Y., Nagashima, H., Endoh, Y., Iwamoto, Y., Omori, Y., & Takizawa, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1401 · Cited by 175
Hyperglycemic Crises in Patients With Diabetes Mellitus
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.154 · Cited by 174
Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.
Fitzgibbons, J. F., Koler, R. D., & Jones, R. T. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108534 · Cited by 166
MICA Polymorphism Is Associated With Type 1 Diabetes in the Korean Population
Park, Y., Lee, H., Sanjeevi, C. B., & Eisenbarth, G. S. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.33 · Cited by 165
The postprandial state and risk of cardiovascular disease
Lefèbvre, P. J., & Scheen, A. J. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(1998120)15:4+<s63::aid-dia737>3.0.co;2-7 · Cited by 157
Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia
Yudkin, J. S., Forrest, R. D., Jackson, C. A., Ryle, A., Davie, S. J., & GOULD, B. J. (1990) · Diabetologia · doi:10.1007/bf00404798 · Cited by 155
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase.
Delpierre, G., Rider, M. H., Collard, F., Stroobant, V., Vanstapel, F. J. L. A., Santos, H., & SCHAFTINGEN, E. V. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1627 · Cited by 154
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease
Heine, R. J., & Dekker, J. M. (2002) · Diabetologia · doi:10.1007/s00125-001-0726-0 · Cited by 152
The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060
Bagust, A., Hopkinson, P. K., Maslove, L., & Currie, C. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.19.s4.2.x · Cited by 149
Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring
Kilpatrick, E. S., Maylor, P. W., & Keevil, B. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.261 · Cited by 133
An economic model of the long-term health care burden of Type II diabetes
Bagust, A., Hopkinson, P. K., Maier, W., & Currie, C. J. (2001) · Diabetologia · doi:10.1007/s001250100023 · Cited by 128
American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control*
(2002) · Endocrine Practice · doi:10.4158/ep.8.s1.5 · Cited by 124
Management of diabetes: are doctors framing the benefits from the wrong perspective?
Wolpert, H. A., & Anderson, B. J. (2001) · BMJ · doi:10.1136/bmj.323.7319.994 · Cited by 122
Potential new treatments for type 2 diabetes
Bailey, C. J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01506-6 · Cited by 122
Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes
Delpierre, G., Collard, F., Fortpied, J., & SCHAFTINGEN, E. V. (2002) · Biochemical Journal · doi:10.1042/bj20020325 · Cited by 116
Factors Influencing Glycemic Control in Young People With Type 1 Diabetes in Scotland
Scottish Study Group for the Care of the Young Diabetic (2001) · Diabetes Care · doi:10.2337/diacare.24.2.239 · Cited by 115
GOULD, B. J., Davie, S. J., & Yudkin, J. S. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(96)06508-4 · Cited by 108
Temporal relationship of glycosylated haemoglobin concentrations to glucose control in diabetics
Dunn, P. J., Cole, R., Soeldner, J. S., Gleason, R. E., Kwa, E., Firooz-Abadi, H., Younger, D., & Graham, C. A. (1979) · Diabetologia · doi:10.1007/bf01235857 · Cited by 104
Glycosylation of Plasma Protein and its Relation to Glycosylated Hemoglobin in Diabetes
Yue, D. K., Morris, K., McLennan, S. V., & Turtle, J. R. (1980) · Diabetes · doi:10.2337/diab.29.4.296 · Cited by 90
Caputo, S., Pitocco, D., Ruotolo, V., & Ghirlanda, G. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.2011 · Cited by 86
Bouma, M., Dekker, J. H., de Sonnaville, J. J. J., Does, F. E. E. V. D., de Vries, H., Kriegsman, D. M. W., Kostense, P. J., Heine, R. J., & van Eijk, J. T. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.904 · Cited by 77
Standardization of HbA1c measurements − a consensus statement
Marshall, S. M., & Barth, J. H. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00228.x · Cited by 76
Adoption of disease management model for diabetes in region of Maastricht
Vrijhoef, H. J., Spreeuwenberg, C., Eijkelberg, I. M. J. G., Wolffenbuttel, B. H. R., & van Merode, G. G. (2001) · BMJ · doi:10.1136/bmj.323.7319.983 · Cited by 71
John, W. G. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400105 · Cited by 63
Hudson, P. R., Child, D. F., Jones, H., & Williams, C. P. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600408 · Cited by 61
FAST GLYCOSYLATION OF HÆMOGLOBIN
Leslie, R. D., Pyke, D. A., John, P. N., & White, J. M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91224-8 · Cited by 60
Comparison of Combined Therapies in Treatment of Secondary Failure to Glyburide
Trischitta, V., Italia, S., Mazzarino, S., Buscema, M., Rabuazzo, A. M., Sangiorgio, L., Squatrito, S., & Vigneri, R. (1992) · Diabetes Care · doi:10.2337/diacare.15.4.539 · Cited by 47
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s97 · Cited by 46
Interlaboratory comparison of glycohemoglobin results: College of American Pathologists Survey data
Little, R. R., Wiedmeyer, H.-M., England, J. D., Naito, H. K., & Goldstein, D. E. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.10.1725 · Cited by 44
Recent progress in glycohemoglobin (HbA1c) testing.
Little, R. R. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.265 · Cited by 34
Disease management: has it a future?
Hunter, D. J. (2000) · BMJ · doi:10.1136/bmj.320.7234.530 · Cited by 33
What's ahead in glucose monitoring?
Bode, B. W., Sabbah, H. T., & Davidson, P. C. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.04.906 · Cited by 29
New diagnostic criteria for diabetes—are they doing what they should?
Davies, M. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90129-0 · Cited by 29
Weykamp, C. W., Penders, T. J., Muskiet, F. A. J., & van der Slik, W. (1993) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329303000210 · Cited by 24
Is HbA1 Measurement Superfluous in NIDDM?
McCance, D. R., Ritchie, C. M., & Kennedy, L. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.512 · Cited by 15
IGT and IFG. Time for revision?
Borch-Johnsen, K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00858.x · Cited by 14
Hoshine, T., Okahashi, M., & Arai, H. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02050-x · Cited by 12
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S., & Schmidt, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161871.83614.bb · Cited by 404
Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With Diabetes
Kirk, J. K., D’Agostino, R. B., Bell, R. A., Passmore, L. V., Bonds, D. E., Karter, A. J., & Narayan, K. M. V. (2006) · Diabetes Care · doi:10.2337/dc05-1973 · Cited by 332
Review of hemoglobin A1c in the management of diabetes
GALLAGHER, E. J., LE ROITH, D., & BLOOMGARDEN, Z. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00009.x · Cited by 304
Metadata
- Authors
- Jeffcoate, S. L.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2003-11-06
- Volume
- 21
- Issue
- 7
- Pages
- 657-665
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1996084976
- Cited by
- 252
- References
- 91
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.